Plain Language Summary

What is it about?

Many health systems aim to reduce health inequalities between socioeconomic groups, but most policies focus on broader social factors rather than healthcare delivery. Payment systems for healthcare providers, including pay-for-performance schemes rewarding quality targets, could reduce health inequalities but rarely consider equity goals and may inadvertently widen health gaps. This study addresses how to systematically incorporate health inequality concerns into provider payment schemes. The researchers propose a methodology combining distributional cost-effectiveness analysis with economic contract theory to evaluate how payment changes affect both total population health and its distribution across socioeconomic groups. This framework helps decision makers to explicitly consider trade-offs between efficiency (maximizing total health) and equity (reducing health inequalities) when designing financial incentives.

How was the research conducted?

The approach models how general practitioners respond to financial incentives and how these responses affect health outcomes across socioeconomic groups. The researchers applied this framework to England's Quality Outcomes Framework, a pay-for-performance scheme rewarding primary care physicians for meeting quality indicators. They calibrated a mathematical model using real-world data on costs, health benefits, patient populations, and physician responsiveness to payment changes from 300 primary care practices, focusing on 3 quality indicators for diabetes and chronic obstructive pulmonary disease. This method allows systematic evaluation of how hypothetical payment changes affect population health and inequalities, measured using the Equally Distributed Equivalent level of health.

What were the results?

The central finding demonstrates that incorporating health inequality concerns into value-based pricing is feasible and reveals important trade-offs. When payments increased for influenza vaccination in diabetes patients (funded by reducing diabetes education payments), overall population health increased by 1865 quality-adjusted life-years, but inequalities widened because less-deprived patients gained more. A surprising finding came from targeting payments by socioeconomic group: increasing payments for vaccinating the most-deprived patients with diabetes while decreasing payments for the least-deprived reduced overall population health by 309 quality-adjusted life-years yet improved social welfare when inequality aversion was sufficiently high, consistent with public preferences in England.

Why are the results important?

These results demonstrate that uniform payment structures may be insufficient to address health inequalities and may even widen them. The findings could change health policy by providing decision makers a systematic method to design payment schemes that explicitly balance maximizing health and reducing inequalities. Patients from disadvantaged backgrounds benefit because this approach makes visible how payment designs affect their outcomes and provides a framework for directing resources toward reducing health gaps. Long-term implications include more equitable healthcare delivery systems where financial incentives deliberately address disparities, leading to fairer health outcomes across society.

What are the strengths and weaknesses of this study?

The main strength is providing a rigorous, transparent framework for incorporating health equity into healthcare payment design, making trade-offs explicit and quantifiable. The primary limitation is requiring substantial data on health benefits by socioeconomic group, provider responsiveness, and public preferences about inequality, which may not always be readily available. Future research could expand this approach to additional inequality dimensions beyond socioeconomic status and evaluate actual policy changes and their effectiveness.

^{Note: This content was created with assistance from artificial intelligence (AI) and has been reviewed and edited by ISPOR staff. For more information or for inquiries on ISPOR’s AI policy, click here or contact us at info@ispor.org.}